Quinfamide: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Antiparasitic medication}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Quinfamide.svg | |||
| image2 = Quinfamide_synthesis.svg | |||
}} | |||
'''Quinfamide''' is an [[antiparasitic]] medication primarily used in the treatment of [[amoebiasis]], a parasitic infection of the intestines caused by the protozoan [[Entamoeba histolytica]]. It is particularly effective against the [[cyst]] form of the parasite, which is responsible for transmission and infection. | |||
Quinfamide works by inhibiting the | ==Mechanism of Action== | ||
Quinfamide works by inhibiting the [[DNA]] synthesis of the [[Entamoeba histolytica]] cysts, thereby preventing their replication and survival. This action disrupts the life cycle of the parasite, leading to its eventual elimination from the host's body. The drug is specifically designed to target the cysts, which are the dormant and resistant form of the parasite, making it effective in preventing the spread of infection. | |||
== | ==Pharmacokinetics== | ||
Quinfamide is administered orally and is known for its poor absorption in the gastrointestinal tract, which is beneficial as it allows the drug to act directly in the intestines where the [[Entamoeba histolytica]] resides. The drug is minimally metabolized and is excreted primarily in the feces. | |||
==Clinical Use== | |||
Quinfamide is used in the treatment of intestinal amoebiasis, particularly in cases where the infection is asymptomatic or in the cystic stage. It is not typically used for invasive forms of amoebiasis, such as [[amoebic dysentery]] or [[liver abscess]], where other medications like [[metronidazole]] are preferred. | |||
== | ==Side Effects== | ||
The side effects of quinfamide are generally mild and may include [[nausea]], [[abdominal pain]], and [[diarrhea]]. Due to its limited absorption, systemic side effects are rare. | |||
==Synthesis== | |||
[[File:Quinfamide_synthesis.svg|thumb|right|Synthesis of Quinfamide]] | |||
== | The synthesis of quinfamide involves the chemical modification of a quinoline derivative. The process includes the introduction of functional groups that enhance its antiparasitic activity and specificity for the [[Entamoeba histolytica]] cysts. | ||
==Related Pages== | |||
* [[Amoebiasis]] | |||
* [[Entamoeba histolytica]] | |||
* [[Antiparasitic drugs]] | * [[Antiparasitic drugs]] | ||
* [[ | * [[Metronidazole]] | ||
[[Category:Antiparasitic agents]] | |||
[[Category:Quinolines]] | |||
[[Category:Drugs acting on the gastrointestinal system]] | |||
Latest revision as of 19:00, 23 March 2025
Antiparasitic medication
| Quinfamide | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Quinfamide is an antiparasitic medication primarily used in the treatment of amoebiasis, a parasitic infection of the intestines caused by the protozoan Entamoeba histolytica. It is particularly effective against the cyst form of the parasite, which is responsible for transmission and infection.
Mechanism of Action[edit]
Quinfamide works by inhibiting the DNA synthesis of the Entamoeba histolytica cysts, thereby preventing their replication and survival. This action disrupts the life cycle of the parasite, leading to its eventual elimination from the host's body. The drug is specifically designed to target the cysts, which are the dormant and resistant form of the parasite, making it effective in preventing the spread of infection.
Pharmacokinetics[edit]
Quinfamide is administered orally and is known for its poor absorption in the gastrointestinal tract, which is beneficial as it allows the drug to act directly in the intestines where the Entamoeba histolytica resides. The drug is minimally metabolized and is excreted primarily in the feces.
Clinical Use[edit]
Quinfamide is used in the treatment of intestinal amoebiasis, particularly in cases where the infection is asymptomatic or in the cystic stage. It is not typically used for invasive forms of amoebiasis, such as amoebic dysentery or liver abscess, where other medications like metronidazole are preferred.
Side Effects[edit]
The side effects of quinfamide are generally mild and may include nausea, abdominal pain, and diarrhea. Due to its limited absorption, systemic side effects are rare.
Synthesis[edit]
The synthesis of quinfamide involves the chemical modification of a quinoline derivative. The process includes the introduction of functional groups that enhance its antiparasitic activity and specificity for the Entamoeba histolytica cysts.
